Acquiring Company
Boston Scientific
Acquired Company
Penumbra
MarlboroughAlamedaManufacturingBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedicalDescription
On January 15, 2026, Boston Scientific announced its agreement to acquire Penumbra for approximately $14.5 billion. The deal is structured as 73% cash and 27% stock, aiming to enhance Boston Scientific's position in the neurovascular market. Penumbra's innovative thrombectomy technology is expected to significantly contribute to Boston Scientific's growth strategy.
Quick answer
Boston Scientific is acquiring Penumbra for $14.5 billion, announced February 19, 2026. Boston Scientific is based in Marlborough, Massachusetts, United States.
- How much did Boston Scientific pay for Penumbra?
- The reported deal value is $14.5 billion.
- What does Boston Scientific do?
- Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.
- Where are Boston Scientific and Penumbra based?
- Boston Scientific is based in Marlborough, Massachusetts, United States. Penumbra is based in Alameda, California, United States.
- Who are the decision-makers at Boston Scientific?
- Fundz holds 2 contacts at Boston Scientific. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Embecta to acquire Owen Mumford Holdings Limited (March 19, 2026)
- Medimaps Group merges with Radiobotics for AI growth (March 2, 2026)
- Medtronic to acquire CathWorks for $585 million, $585M (February 3, 2026)
- Intuitive Surgical completes acquisition of da Vinci business (March 10, 2026)
- Merit Medical completes merger with Biolife Delaware (February 28, 2026)
- Danaher acquires Masimo for $9.9 billion, $9.9B (February 18, 2026)
Who to call at Boston Scientific, and when
When Boston Scientific changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Boston Scientific raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Boston Scientific, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Boston Scientific. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Boston Scientific makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Penumbra?
Penumbra was acquired by Boston Scientific, based in Marlborough. The deal was reported on February 19, 2026. Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific is publicly traded (BSX) and operates in Manufacturing.
When did Boston Scientific acquire Penumbra?
Boston Scientific's acquisition of Penumbra was reported on February 19, 2026. On January 15, 2026, Boston Scientific announced its agreement to acquire Penumbra for approximately $14.5 billion. The deal is structured as 73% cash and 27% stock, aiming to enhance Boston Scientific's position in the neurovascular market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Penumbra do?
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. It is privately held, operating in Biotechnology, and is based in Alameda.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.